XeroThera Europe SRL
2.0 FTEXeroThera Europe reported total assets of 820,359 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Aug 2026), with 2 full-time equivalents.
By total assets for 2025, XeroThera Europe ranks in the top half of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of XeroThera Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +277 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
XeroThera Europe's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −36,329 € | ||||
| Equity | 646,920 € | ||||
| Cash | 5,411 € | ||||
| EBITDA | −23,034 € | ||||
| Total assets | 820,359 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
XeroThera Europe's financial analysis
- Solvency78.9%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of XeroThera Europe
XeroThera Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0697.932.717
- VAT number
- BE0697932717
- Peppol
- Registered · 0208:0697932717 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Jun 2018
- Registered office
- 4000 Liège
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 14 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
XeroThera Europe (SRL) has been based in Liège since 2018, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 36,329 € and equity of 646,920 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 78.9%, above the median of its sector (46.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to XeroThera Europe
Companies in the same business, of comparable size and area, outside its group.
- Pharma Chemicals France Manufacture of basic pharmaceutical products Braine-le-Château · balance sheet €1.08m
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Galenicap Manufacture of basic pharmaceutical products Ixelles · balance sheet €1.47m
- Plant Bio Technologies Manufacture of basic pharmaceutical products Ghent · balance sheet €1.04m
- Equibor Manufacture of basic pharmaceutical products Manage · balance sheet €1.12m
- Rodilo Manufacture of pharmaceutical preparations Liège · balance sheet 204,587 €
- Curium PET Liège Manufacture of basic pharmaceutical products Liège · balance sheet €1.86m
- OLYS Pharma Manufacture of pharmaceutical preparations La Hulpe · balance sheet €1.03m
Frequently asked questions about XeroThera Europe
What is the revenue of XeroThera Europe?
XeroThera Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of XeroThera Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0697932717 for XeroThera Europe, if the company is VAT-registered. Its company number (CBE) is 0697.932.717.
Where is the registered office of XeroThera Europe?
According to the CBE register, the registered office of XeroThera Europe is in 4000 Liège.
What is the equity of XeroThera Europe?
At the close of the 2025 financial year, the equity of XeroThera Europe amounts to 646,920 €, a solvency of 78.9% of total assets.
How many people work at XeroThera Europe?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages XeroThera Europe?
The register lists 1 active mandates at XeroThera Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is XeroThera Europe within its sector?
By total assets for 2025, XeroThera Europe ranks in the top half of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.
The full file of XeroThera Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →